Thomas Lendvay, MD
Chief Medical Officer

Dr. Thomas (Tom) Lendvay is a Pediatric Urologist at Seattle Children’s Hospital and a professor in the Urology department at the University of Washington. Dr. Lendvay was the Lead Author of the 2020 WHO-led DeMaND Study peer-reviewed and published in Infection Control and Hospital Epidemiology (2021) which validated the Antimicrobial Photodynamic Inactivation (aPDI) method of pathogen inactivation. Follow-on studies are peer-reviewed and published in the American Journal of Infection Control (2022), including research authored by Lendvay, et al.

Lendvay was honored with the UW Medical School Inventor of the Year Award in 2018 for creating Crowd-Sourced Assessment of Technical Skills (CSATS) technology. He is also Chief Medical Officer for Tend-Health, Inc., a transformative microbiome restoration technology. His credentials include a Bachelor of Arts in Biology and German from Rice University and a Doctor of Medicine from Temple University.